Policy liaison initiative: Relevant and accessible evidence from The Cochrane Library
Logo for Australasian Cochrane Centre
Arthritis & Musculoskeletal Asthma Cancer Cardiovascular Diabetes Injury Mental Health

Policy liaison home
Review summaries
Cochrane & Public Health
Topics & Reviews
Review summaries
Australia's contribution 
Impact on health care
Research priorities

Other policy relevant Cochrane work 
Effective Practice and Organisation of Care
Consumers and Communication 
Public Health

Evidence-Based Policy Network 
About the EBPN
Events
Bulletin -
latest news
Helpdesk for EBPN


Resources 
Cochrane Library logon
Cochrane Library guide
Australasian Cochrane Centre

Public Health reviews by topic

Issue 10, 2010 of The Cochrane Library included 11 new and no updated reviews on public health.  A full list of topics and reviews can be viewed below. 

Click on the title to view the full review or protocol

Log on to The Cochrane Library to read protocols and full reviews. (click here for search tip)

[R] Cochrane review

[P] Protocol for Cochrane review
[S] Summary of Cochrane review available

Quick links to topics:

Topic Reviews and Protocols 
Click on title to view review or protocol
Tobacco Addiction

Prevention: 

  1. Community interventions for preventing smoking in young people  [R]
  2. Family-based programmes for preventing smoking by children and adolescents  [R]
  3. Interventions for preventing tobacco sales to minors  [R]
  4. Interventions to reduce harm from continued tobacco use [R]
  5. Mass media interventions for preventing smoking in young people  [R]
  6. Mentoring of children and adolescents for preventing drug and alcohol use  [P]
  7. School-based programmes for preventing smoking  [R]

Cessation: 

  1. Acupuncture and related interventions for smoking cessation  [R]
  2. Antidepressants for smoking cessation  [R]
  3. Anxiolytics for smoking cessation  [R]
  4. Aversive smoking for smoking cessation  [R]  [S]
  5. Biomedical risk assessment as an aid for smoking cessation  [R]
  6. Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation  [R]
  7. Clonidine for smoking cessation  [R]
  8. Combined pharmacotherapy and behavioural interventions for smoking cessation  [P]
  9. Competitions and incentives for smoking cessation  [R]
  10. Enhancing partner support to improve smoking cessation  [R]
  11. Exercise interventions for smoking cessation  [R]
  12. Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke  [R]
  13. Group behaviour therapy programmes for smoking cessation  [R]
  14. Healthcare financing systems for increasing the use of tobacco dependence treatment  [R]
  15. Hypnotherapy for smoking cessation  [R]
  16. Individual behavioural counselling for smoking cessation  [R]
  17. Internet-based interventions for smoking cessation [R]
  18. Interventions for smoking cessation in hospitalised patients  [R]
  19. Interventions for preoperative smoking cessation  [R]
  20. Interventions for preventing weight gain after smoking cessation  [R]
  21. Interventions for promoting smoking cessation during pregnancy  [R]
  22. Interventions for waterpipe smoking cessation  [R]
  23. Lobeline for smoking cessation  [R]
  24. Mass media interventions for smoking cessation in adults  [R]
  25. Mecamylamine (a nicotine antagonist) for smoking cessation  [R]
  26. Mobile phone-based interventions for smoking cessation  [R]  [S]
  27. Motivational interviewing for smoking cessation  [R]  [S]
  28. Nicobrevin for smoking cessation  [R]  [S]
  29. Nicotine receptor partial agonists for smoking cessation  [R]
  30. Nicotine replacement therapy for smoking cessation  [R]
  31. Nursing interventions for smoking cessation [R]
  32. Nicotine vaccines for smoking cessation  [P]
  33. Opioid antagonists for smoking cessation  [R]  [S]
  34. Physician advice for smoking cessation  [R]
  35. Quit and Win contests for smoking cessation  [R]
  36. Reduction versus abrupt cessation in smokers who want to quit [R]
  37. Relapse prevention interventions for smoking cessation  [R]
  38. Silver acetate for smoking cessation  [R]
  39. Self-help interventions for smoking cessation  [R]  [S]
  40. Smoking cessation interventions for smokers with current or past depression  [P]
  41. Telephone counselling for smoking cessation  [R]
  42. Tobacco cessation interventions for young people  [R]  [S]
  43. Training health professionals in smoking cessation  [R]
  44. Workplace interventions for smoking cessation  [R]

 

Back to Top

Infectious diseases

Prevention of influenza: 

  1. Amantadine and rimantadine for influenza A in adults  [R]
  2. Amantadine and rimantadine for influenza A in children and the elderly  [P]
  3. Conjugate vaccines for preventing Haemophilus influenzae type B infections  [R]
  4. Influenza vaccination for healthcare workers who work with the elderly  [R]
  5. Interventions for the interruption or reduction of the spread of respiratory viruses  [P]
  6. Interventions to increase influenza vaccination rates of those 60 years and older in the community and in institutions  [P]
  7. Neuraminidase inhibitors for preventing and treating influenza in children  [R]
  8. Neuraminidase inhibitors for preventing and treating influenza in healthy adults  [R]
  9. Vaccines for preventing influenza in healthy adults  [R]
  10. Vaccines for preventing influenza in healthy children  [R]
  11. Vaccines for preventing influenza in the elderly  [R]

 

Treatment of influenza: 

  1. Amantadine and rimantadine for influenza A in adults  [R]
  2. Amantadine and rimantadine for influenza A in children and the elderly  [P]
  3. Chinese medicinal herbs for influenza  [R]
  4. Neuraminidase inhibitors for preventing and treating influenza in children  [R]
  5. Neuraminidase inhibitors for preventing and treating influenza in healthy adults  [R]

Prevention of meningitis: 

  1. Antibiotics for preventing meningococcal infections  [R]
  2. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia  [R]
  3. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis  [R]

Treatment of meningitis: 

  1. Anti-cytokine and anti-endotoxin therapies in meningococcal disease  [P]

 

Back to Top

Aging

Dementia and cognitive impairment: 

  1. Acetyl-l-carnitine for dementia  [R]
  2. Alpha lipoic acid for dementia  [R]
  3. Aroma therapy for dementia  [R]
  4. Cognitive and behavioural interventions for carers of people with dementia  [P]
  5. Cognitive stimulation to improve cognitive functioning in people with dementia  [P]
  6. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly  [R]
  7. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people  [R]  [S]
  8. Donepezil for mild cognitive impairment  [R]
  9. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia  [R]
  10. Folic acid with or without vitamin B12 for cognition and dementia  [R]
  11. Ginkgo Biloba for cognitive impairment and dementia  [R]
  12. Ginkgo biloba for cognitive improvement in healthy individuals  [P]
  13. Homeopathy for dementia  [R]
  14. Hormone replacement therapy to maintain cognitive function in women with dementia  [R]
  15. Hydergine for dementia  [R]
  16. Lecithin for dementia and cognitive impairment  [R]
  17. Light Therapy for Managing Sleep, Behaviour, and Mood Disturbances in Dementia  [R]
  18. Melatonin for cognitive impairment  [R]
  19. Music therapy for people with dementia  [R]
  20. Omega 3 fatty acid for the prevention of dementia  [R]
  21. Physical activity and enhanced fitness to improve cognitive function in older people  [P]
  22. Piracetam for dementia or cognitive impairment  [R]
  23. Procaine treatments for cognition and dementia  [P]
  24. Thioridazine for dementia  [R]
  25. Vitamin B6 for cognition  [R]
  26. Vitamin B12 for cognition  [R]
  27. Valproate preparations for agitation in dementia  [R]

Back to Top

Last updated 22 Oct 2010

This website is produced and maintained  by the Australasian Cochrane Centre for members of the Evidence-Based Policy Network, Australian Government Department of Health and Ageing.